Therapeutic use of somatostatin peptides

Details Therapeutic use of somatostatin peptides Therapeutic use of somatostatin peptides

1994-06-13

2000-09-26

Achutamurthy, Ponnathapu

Drug, bio-affecting and body treating compositions

Radionuclide or intended radionuclide containing; adjuvant...

In an organic compound

424 111, 424 141, 514 11, 514 14, 514 15, 514 16, 530311, 530317, 930160, A61K 5100, A61K 3812, A61K 3831

Patent

active

06123916&

ABSTRACT:
The invention relates to a new pharmaceutical use of somatostatin peptides comprising on the terminal amino group a polyamino polycarboxylic group, in free form or in a pharmaceutically acceptable salt form, particularly in the manufacture of a medicament for treating disorders with an aetiology comprising or associated with excess of GH-secretion.

REFERENCES:
patent: Re30548 (1981-03-01), Vale, Jr. et al.
patent: 4725577 (1988-02-01), Schalley et al.
patent: 4812554 (1989-03-01), Riggs et al.
patent: 4853371 (1989-08-01), Coy et al.
patent: 5225180 (1993-07-01), Dean et al.
patent: 5382654 (1995-01-01), Lyle et al.
patent: 5384113 (1995-01-01), Deutsch et al.
Moi et al, Analytical Biochem. 148:249-253 (1985).
Cai et al, PNAS USA 83:1896-1900 (1986).
Krenning et al (1989) The Lancet 1:242-245.
Brechbiel et al (1986) Inorg. Chem. 25:2772-2781.
Reubi et al (1987) J. Clin. Endocrin. Metabolism 65(6):1127-34.
Bakker et al (1990) J. Nucl. Med. 31:1501-1509.
Bakker et al (1991) Life Sciences 49:1583-1591.
Bakker et al. (1991) Life Sciences 49:1593-1601.

Affiliated with

Also associated with

Rating

Therapeutic use of somatostatin peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic use of somatostatin peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic use of somatostatin peptides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2097349